LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells.

MLA

Li, Weidong, et al. “LncRNA SNHG1 Contributes to Sorafenib Resistance by Activating the Akt Pathway and Is Positively Regulated by MiR-21 in Hepatocellular Carcinoma Cells.” Journal of Experimental & Clinical Cancer Research (17569966), vol. 38, no. 1, May 2019, p. N.PAG. EBSCOhost, https://doi.org/10.1186/s13046-019-1177-0.

APA

Li, W., Dong, X., He, C., Tan, G., Li, Z., Zhai, B., Feng, J., Jiang, X., Liu, C., Jiang, H., & Sun, X. (2019). LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells. Journal of Experimental & Clinical Cancer Research (17569966), 38(1), N.PAG. https://doi.org/10.1186/s13046-019-1177-0

Chicago

Li, Weidong, Xuesong Dong, Changjun He, Gang Tan, Ziyi Li, Bo Zhai, Jing Feng, et al. 2019. “LncRNA SNHG1 Contributes to Sorafenib Resistance by Activating the Akt Pathway and Is Positively Regulated by MiR-21 in Hepatocellular Carcinoma Cells.” Journal of Experimental & Clinical Cancer Research (17569966) 38 (1): N.PAG. doi:10.1186/s13046-019-1177-0.